|Anti-FYb||BGFYB002||1 x 2ml|
The FYa and FYb antigens were reported in 1950 and 1951 respectively. Anti-FYb has been implemented in immediate and delayed Haemolytic Transfusion reactions and Haemolytic Disease in the new born. Indirect agglutination of red cells that carry the FYb – antigen occurs in the antiglobulin phase. In the absence of the FYb– antigen, no indirect agglutination is generally observed.
The Biorex Diagnostics Anti-FYB reagent consists of human serum diluted in sodium chloride solution containing macromolecular potentiators and bovine albumin. The reagent requires no further dilution or addition for recommended techniques.